3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasms
2
Head and Neck Neoplasms
2
Triple Negative Breast Neoplasms
1
Tracheal Diseases
1
TP53 Y220C Mutation
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Overweight
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Interventions
enzalutamide
92
Magnetic Resonance Spectroscopy
87
Specimen Handling
66
Prednisone
65
Androgen Antagonists
59
Abiraterone Acetate
59
apalutamide
56
Radiosurgery
53
Radiotherapy
47
Leuprolide
47
darolutamide
46
abiraterone
44
Docetaxel
43
Radiation
31
Pluvicto
31
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
30
Biopsy
30
relugolix
28
Surveys and Questionnaires
28
pembrolizumab
26
gallium 68 PSMA-11
26
Standard of Care
26
Triptorelin Pamoate
25
Goserelin
25
bicalutamide
23
Gonadotropin-Releasing Hormone
23
Brachytherapy
21
Carboplatin
20
X-Rays
19
luprolide acetate gel depot
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Tablets
×
1 year
×
Clear all
No trials found.